Daily non-political popular news in brief.

Men, don't skip your prostate cancer treatment appointments!

Men with 'low risk' prostate cancer who miss more than two radiation treatments in an eight week treatment face an increased chance of their cancer recurring. That is the conclusion of a new study examining more than 15 years of data and nearly 1,800 patients treated at Fox Chase Cancer Center in Philadelphia.

Read more »

Keywords: men, skip, prostate, cancer, treatment, appointments, appointment

« Previous | Next »

Similar news on "Men, don't skip your prostate cancer treatment appointments!":

1. UCLA study finds prostate cancer treatments impact on quality of life
   04-23-2007 · EurekAlert!
   A rigorous, long-term study of quality of life in patients who underwent one of the three most common treatments for prostate cancer found that each affected men's lives in different ways. The findings provide invaluable information for men with prostate cancer who are facing vital treatment decisions.
   Similar news · Read more »
   
2. IMRT versus 3D CRT for prostate cancer, new long-term data assesses side effects
   11-05-2006 · EurekAlert!
   New research findings show men have fewer long-term gastrointestinal side effects with intensity-modulated radiation therapy (IMRT) than with three-dimensional conformal radiation therapy (3D CRT) for prostate cancer treatment, despite the higher doses of radiation used in the IMRT group. These and other data, including long-term genitourinary side effects, were presented today.
   Similar news · Read more »
   
3. Radiation therapy combo cures prostate cancer long-term
   01-04-2007 · EurekAlert!
   Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study released today in the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.
   Similar news · Read more »
   
4. Men with prostate cancer avoid radiation due to misconceptions
   11-05-2006 · EurekAlert!
   Negative perceptions about radiation therapy can strongly influence a prostate cancer patient's choice to avoid external beam radiation therapy, even though studies have proven the treatment to be as safe and effective as other treatments for the disease, including surgery, according to a study presented November 5, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
   Similar news · Read more »
   
5. Largest study to evaluate PSA 'bounce' shows overall survival is not affected
   11-08-2006 · EurekAlert!
   A study involving more than 7,500 men with prostate cancer treated with radiation concludes that a rise in the PSA level after treatment -- called PSA bounce -- does not have clinical relevance and does not affect survival. The results of this multi-institutional study will be presented today.
   Similar news · Read more »
   
6. Adding radiation therapy for treatment of advanced prostate cancer may offer benefit
   11-14-2006 · EurekAlert!
   Treating advanced prostate cancer with radiation therapy after removal of the prostate gland reduces the risk of disease recurrence, but does not appear to significantly improve the length of survival, according to a study in the Nov. 15 issue of JAMA, a theme issue on men's health.
   Similar news · Read more »
   
7. Older men treated for early prostate cancer live longer than those who are not
   12-12-2006 · EurekAlert!
   Recent findings of an observational study by researchers at the University of Pennsylvania School of Medicine suggest that men between 65-80 years of age who received treatment for early stage, localized prostate cancer lived significantly longer than men who did not receive treatment. The study will be published in the Dec. 13 issue of JAMA.
   Similar news · Read more »
   
8. 'Mismatched' prostate cancer treatment more common than expected
   11-26-2007 · EurekAlert!
   More than a third of men with early prostate cancer who participated in a study analyzing treatment choice received therapies that might not be appropriate, based on pre-existing problems with urinary, bowel or sexual function. The prevalence of these treatment "mismatches" could reflect patient unwillingness to discuss such problems with their physicians.
   Similar news · Read more »
   
9. New classification better identifies prostate cancer patients to benefit from hormone therapy
   11-08-2006 · EurekAlert!
   A new classification system for evaluating men after radiation treatment for prostate cancer better determines which men may recur and thus may benefit from hormone therapy. Doctors applied the new system to 1,831 previously treated patients. The new classification could alter the course of treatment, which may include hormone therapy sooner and for more men. The study demonstrates a significant improvement in predicting endpoints, including distant metastasis, cause-specific mortality and overall mortality.
   Similar news · Read more »
   
10. Analysis: Older men treated for early prostate cancer
    12-12-2006 · EurekAlert!
    An analysis of Surveillance, Epidemiology and End Results-Medicare records for 44,630 older men suggests surgery or radiation therapy for early-stage prostate cancer increased the lifespan of men between 65 and 80 years old compared to observation, sometimes known as "watch and wait." The study supported a benefit of treatment even for men whose disease had a low risk of spreading, and even if they were elderly men (75 to 80 years old).
    Similar news · Read more »